Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Y-shape pegylated somatropin1件: Somatotropin---1件: 78
2YAM80----1件: 2
3Yarrowia lipolytica lipase----1件: 298
4Yellow fever vaccine1件: Yellow fever vaccine1件: D06347 --8件: 40, 44, 46, 50, 51, 52, 53, 107
5Yellow Fever vaccine (17D)1件: Yellow fever vaccine1件: D06347 --8件: 40, 44, 46, 50, 51, 52, 53, 107
6Yisaipu1件: Yisaipu---2件: 46, 271
7Yisaipu®1件: Yisaipu---1件: 271
8YISAIPU® ( An etanercept biosimilar)2件: Etanercept,
Yisaipu		1件: D00742 2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
9YLB113----1件: 46
10YM672----1件: 226
11YM672 (IPD®)----1件: 226
12Yohimbine1件: Yohimbine1件: D08685 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6
13Yohimbine HCl1件: Yohimbine1件: D08685 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6
14Yondelis1件: Trabectedin1件: D06199 --1件: 159
15YONDELIS 0,25 mg polvo para concentrado para solución para perfusión1件: Trabectedin1件: D06199 --1件: 159
16Yondelis 0.25 mg powder for concentrate for solution for infusion.1件: Trabectedin1件: D06199 --1件: 159
17YONDELIS 1 mg polvo para concentrado para solución para perfusión1件: Trabectedin1件: D06199 --1件: 159
18Yondelis 1 mg powder for concentrate for solution for infusion.1件: Trabectedin1件: D06199 --1件: 159
19YRA-1909 high dose----1件: 46
20YRA-1909 low dose----1件: 46
21YRA-1909 mid dose----1件: 46
22Yttrium-901件: Yttrium Y-90---1件: 28
23Yttrium-90 radiolabelled anti-CD66 antibody1件: Yttrium Y-90---1件: 28
24Yttrium­90 radiolabelled anti­CD661件: Yttrium Y-90---1件: 28
25Yu-Shen formula----1件: 224
26Yuxuebi tablet----1件: 271